May 07, 2020
CryoLife Initiates Enrollment in PROACT Xa Clinical Trial
Apr 16, 2020
Aging Populations Will Increase Demand in the $35,802 Million Antithrombotic Drugs Market, Reports TBRC
Mar 25, 2020
Apixaban (CAS 503612-47-3) Market Research Report 2020 - ResearchAndMarkets.com
Mar 05, 2020
New Data Demonstrates Andexxa® Can Provide a Net Cost Reduction for the Treatment of Intracranial Hemorrhage Associated with Oral Factor Xa Inhibitors
Jan 03, 2020
UNC School of Medicine Expert Helps Treat Astronaut’s Blood Clot During NASA Mission
Dec 23, 2019
FDA approves first generics of Eliquis
Dec 23, 2019
CryoLife Receives FDA Authorization to Commence PROACT Xa Clinical Trial
Aug 05, 2019
New findings provide definitive management guidelines for patients on direct oral anticoagulants with atrial fibrillation undergoing elective procedures or surgeries
Jul 31, 2019
Global Anticoagulants (Xarelto, Eliquis, Pradaxa, Savaysa) Market 2019-2023
May 31, 2019
Anticoagulants Market, 2024 - Focus on Oral Anticoagulants & Injectable Anticoagulants (Unfractionated Heparin, & Low Molecular Weight Heparin)
Mar 01, 2019
Anticoagulants - Global Market Outlook to 2024 with Profiles on 48 Players
Sep 08, 2018
Aniara Diagnostica Launches http://www.DOACtesting.com Providing Specific Product Information For Direct Oral Anticoagulant Testing
May 24, 2018
AGC Biologics Cleared for Commercial Manufacture of Portola's FDA-Approved Andexxa®
Apr 30, 2018
Apixaban Market Extensive Analysis of Supply And Demand, Revenue, Risk and Share 2018-2025
Jan 25, 2018
New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment